Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7395 p415
8 April 2006

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

Letters

· Medicines use reviews
· Packaging (2)
· CVD
· Drug trials
· Product data
· Technology
· Allergy
· Boots/Alliance merger
· NEL LPC
· Council elections
· Conferences
· Registration
· April Fool (5)


Letters to the Editor

Medicines use reviews

Need to reconsider “10-minute” campaign

From Dr F. R. Goldstein, MRPharmS, and others

As a primary care trust, we are committed to supporting our pharmacists with their undertaking of medicines use reviews (MURs). We have a system set up whereby we receive feedback on MURs and we have been impressed by the quality and outcomes. It is therefore of great concern to us that Lloydspharmacy is advocating, via its advertising campaign, that an MUR can be conducted in 10 minutes.

Although we acknowledge the need to recruit patients and to manage an MUR service as part of the routine work of a pharmacy, we are concerned that the “10- minute” message undervalues the usefulness of a MUR, misguides patients with regard to the time an MUR will take and finally places extreme pressure on pharmacists to complete the review.

Our evidence suggests that on average, an MUR will require a minimum of 20 minutes’ patient contact. Within this time frame, the pharmacist is able to provide valuable information and advice to a patient regarding his or her medicines. If pharmacists are pressured to conduct their reviews in less time, the quality of the reviews will inevitably suffer.

We would encourage Lloydspharmacy to reconsider its advertising campaign on MURs and offer a more professional and suitable timescale.

Ruth Goldstein
Community Pharmacist Facilitator
Genine Riley
Head of Medicines Management
Richard Jenkins
Clinical Governance and Prescribing Lead
Burntwood Lichfield and Tamworth Primary Care Trust

 

ANDY MURDOCK, pharmacy director at Lloydspharmacy replies:

It is pleasing to note that the primary care trust’s view of the service is consistent with our own and that it is committed to supporting the profession to deliver what, we would all agree, is a valuable patient service.

Our campaign is based on a general professional view. The Pharmaceutical Services Negotiating Committee guidance titled “10 steps to success with medicines use reviews” uses the 10-minute message at several points to encourage conversation and engagement between the pharmacist and patient.

Our “10-minute” message, based on the advice above, is a constructive approach, using marketing techniques and concepts to ensure that we obtain patient engagement — which is crucial.

We have been quite clear in our extensive training, in our advertising, both window poster and explanatory leaflet, that everyone has different needs, so that the review may be of variable time and, indeed, we state “we do not mind if it takes longer”.

Within the contract, funding for the service was based on a 30-minute timing, which also included preparation and “wash up” time. If the PCT believes that the essential patient contact time is averaging out at around 20 minutes then I would suggest that the current MUR fee is inadequate. On that basis would the PCT assist the PSNC in recommending an elevated fee?

Lloydspharmacy has placed tremendous effort in ensuring that all our pharmacies and pharmacists have been extensively trained and are engaging in this service. To date, we have carried out in excess of 50,000 MURs — more than any other provider. We are extremely proud of what we are doing and are committed to delivering this contract as I hope our actions are demonstrating. It is on that basis that I cannot accept Dr Goldstein’s arguments and hope that she and her colleagues will ultimately be persuaded by our results as we continue our efforts in this area.

Send your letter to The Editor

Next Topic (Packaging)

Back to Top


©The Pharmaceutical Journal